Detection of human antibody against the human papillomavirus type 16 E7 protein. 1991

M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
Department of Virology, University of Tokyo.

We examined 500 human sera for the presence of antibody against the human papillomavirus type 16 E7 protein by enzyme-linked immunosorbent assay with bacterially expressed fusion protein lac-E7, and by radioimmunoprecipitation and immunofluorescence assays with the E7 protein expressed in monkey COS-1 cells. The anti-E7 antibody was detectable in 6 out of 54 cases of cervical carcinoma, but in none of the others, including patients with other gynecologic cancers, those with sexually transmitted diseases, and healthy adults. The data indicate that expression of the E7 protein is closely related to cervical carcinoma.

UI MeSH Term Description Entries
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
January 1995, Japanese journal of cancer research : Gann,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
January 2001, Archives of virology,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
September 1996, Biochemical and biophysical research communications,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
June 2004, Cancer gene therapy,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
May 2019, Molecular immunology,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
November 1987, The Journal of general virology,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
February 2002, Applied and environmental microbiology,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
June 1989, Journal of virology,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
November 1999, Human gene therapy,
M Hashido, and T Kanda, and S Zanma, and S Watanabe, and N Komiyama, and H Yoshikawa, and N Yamaguchi, and T Kawana, and K Yoshiike
May 1989, Virology,
Copied contents to your clipboard!